Canbex Therapeutics Announces the Appointment of New Chief Medical Officer
Canbex Therapeutics Ltd announced today the appointment of Dr Alberto Lledó as its new Chief Medical Officer (CMO), effe…
Canbex Therapeutics Ltd announced today the appointment of Dr Alberto Lledó as its new Chief Medical Officer (CMO), effe…
Canbex Therapeutics Ltd announced today that it has commenced a Phase I clinical trial to assess the safety and tolerabi…
Canbex Therapeutics Ltd announced that it has secured a grant of £1.25M to further support the development of VSN16R. Al…
Canbex Therapeutics Ltd announced today that it has completed a £2.1m ($3.2m) fundraising round that will enable the Com…
Anergis SA is a clinical-stage biopharmaceutical company developing innovative immunotherapies against allergies. Its le…